Table 3.
Factors associated with completed TLTBI. Univariate and multivariate analyses (n = 111)
| Univariate Analysis |
Multivariate Analysis |
|||||
|---|---|---|---|---|---|---|
| Variables |
Crude OR |
(95% CI) | p value | Adjusted OR | (95% CI) | P value |
| Sex | ||||||
| Female | 1 | 1 | ||||
| Male | 1.2 | (0.9-1.6) | 0.244 | 2.1 | (0.9-4.9) | 0.081 |
| Age group (years) | ||||||
| 19-29 | 1 | 1 | ||||
| 30-34 | 1.1 | (0.4-2.9) | 0.808 | 1.2 | (0.3-5.1) | 0.789 |
| 35-38 | 1.2 | (0.4-3.5) | 0.702 | 1.4 | 0.4-4.5) | 0.599 |
| 39-61 | 3.6 | (1.1-11.9) | 0.035 | 2.9 | (0.6-13.1) | 0.173 |
| HIV transmission route | ||||||
| IDU | 1 | 1 | ||||
| MSM | 1.7 | (0.2-12.3) | 0.606 | 2.0 | (0.3-12.2) | 0.458 |
| Heterosexual | 3.6 | (1.3-9.8) | 0.010 | 4.6 | (1.4-14.7) | 0.010 |
| Other/Unknown | 1.0 | (0.1-13.7) | 0.979 | 1.3 | (0.2-7.6) | 0.793 |
| Type of TLTBI | ||||||
| 9H | 1 | 1 | ||||
| 6H | 0.9 | (0.3-2.9) | 0.861 | 0.6 | (0.2-2.2) | 0.505 |
| 12H | 0.6 | (1.1-2.2) | 0.423 | 0.6 | (0.2-1.9) | 0.382 |
| 2RZ | 9.6 | (1.1-81.4) | 0.037 | 8.3 | (2.7-24.9) | 0.000 |
| 3RH | 1.9 | (0.2-21.1) | 0.591 | 1.7 | (0.1-24.2) | 0.702 |
OR: Odds ratio; CI: confidence interval
TLTBI: Treatment of latent tuberculosis infection; IDU: Intravenous drug user; MSM: Men who have sex with men; H: isoniazid; R: rifampin; Z: pyrazinamide
Multivariate model adjusted by hospital